|
1.
|
Alphagan
|
Gtt Opht 0.2 %
|
5 ml
|
8.67
|
25.85
|
01.02.2023
|
|
|
|
Nein
|
54605013
|
AbbVie AG
|
Brimonidini tartras
|
17291
|
15.03.1999
|
|
|
|
O
|
11.09.
|
S01EA05
|
|
2.
|
Alphagan
|
Gtt Opht 0.2 %
|
3x 5 ml
|
22.15
|
40.35
|
01.02.2023
|
|
|
|
Nein
|
54605021
|
AbbVie AG
|
Brimonidini tartras
|
17291
|
15.03.1999
|
|
|
|
O
|
11.09.
|
S01EA05
|
|
3.
|
Arteoptic LA
|
Gtt Opht 2 %
|
Fl 3 ml
|
4.57
|
14.20
|
01.12.2025
|
|
|
|
Nein
|
55733002
|
Bausch & Lomb Swiss AG Division Pharma
|
Carteololi hydrochloridum
|
17741
|
01.04.2002
|
|
|
|
|
11.09.
|
S01ED05
|
|
4.
|
Arteoptic LA
|
Gtt Opht 2 %
|
3 Fl 3 ml
|
11.70
|
29.15
|
01.12.2025
|
|
|
|
Nein
|
55733004
|
Bausch & Lomb Swiss AG Division Pharma
|
Carteololi hydrochloridum
|
17741
|
01.04.2002
|
|
|
|
|
11.09.
|
S01ED05
|
|
5.
|
Arteoptic LA UD
|
Gtt Opht 2 %
|
30 Unidos 0.2 ml
|
6.74
|
16.55
|
01.12.2025
|
|
|
|
Nein
|
56215004
|
Bausch & Lomb Swiss AG Division Pharma
|
Carteololi hydrochloridum
|
17954
|
01.12.2003
|
|
|
|
|
11.09.
|
S01ED05
|
|
6.
|
Azarga
|
Susp Opht
|
5 ml
|
11.35
|
28.75
|
01.12.2025
|
|
|
|
Nein
|
59179001
|
Novartis Pharma Schweiz AG
|
Brinzolamidum
|
19100
|
01.08.2009
|
|
|
|
|
11.09.
|
S01ED51
|
|
7.
|
Azarga
|
Susp Opht
|
3x 5 ml
|
32.36
|
51.60
|
01.12.2025
|
|
|
|
Nein
|
59179002
|
Novartis Pharma Schweiz AG
|
Brinzolamidum
|
19100
|
01.08.2009
|
|
|
|
|
11.09.
|
S01ED51
|
|
8.
|
Azopt
|
Susp Opht
|
5 ml
|
8.96
|
26.15
|
01.12.2025
|
|
|
|
Nein
|
55236001
|
Novartis Pharma Schweiz AG
|
Brinzolamidum
|
17487
|
01.07.2000
|
|
|
|
|
11.09.
|
S01EC04
|
|
9.
|
Azopt
|
Susp Opht
|
3x 5 ml
|
22.86
|
41.30
|
01.12.2025
|
|
|
|
Nein
|
55236003
|
Novartis Pharma Schweiz AG
|
Brinzolamidum
|
17487
|
01.07.2000
|
|
|
|
|
11.09.
|
S01EC04
|
|
10.
|
Betoptic S
|
Gtt Opht
|
5 ml
|
4.51
|
14.15
|
01.12.2025
|
|
|
|
Nein
|
51760018
|
Medius AG
|
Betaxololum
|
16501
|
15.03.1996
|
|
|
|
|
11.09.
|
S01ED02
|